Easterly Capital
138 Conant St, Suite 100, Beverly, MA, 01915, United States
Overview
Easterly Partners is a privately held investment management firm based in Washington, DC. The firm’s strategy aims to provide investors with value-added returns with a core risk profile. Easterly Partners’ focus is to produce an attractive yield for investors with an emphasis on capital preservation. Easterly Partners is led by real estate and investment management professionals with extensive experience navigating both up and down economic real estate cycles. The team has expertise in acquisitions, dispositions, market research, asset management, capital markets, and financing. Easterly Partners’ strong real estate platform is enhanced by unparalleled knowledge and relationships within the GSA sector.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Asset Management
- Finance
Investment portfolio
- Ivenix
Participated · Equity · Sep 2015
Ivenix develops a next-generation infusion system that integrates advanced information technology with a redesigned pump platform to improve accuracy, efficiency, and safety. The Ivenix Infusion System provides immediate, secure access to patient-specific infusion and pump management information and features an intuitive, smartphone-like user interface. The product combines fundamentally new pump technology with IT capabilities to address large-volume infusion delivery and interoperability with hospital EMRs. Ivenix plans to pursue FDA clearance and will use the financing to expand its team ahead of commercial launch. The company highlights a $6 billion global infusion pump market and frames its system as a response to persistent patient safety issues and lack of innovation. Ivenix is headquartered in Amesbury, Massachusetts; the U.S. FDA has not yet reviewed the Ivenix Infusion System. Ivenix provides an infusion management system for hospitals that combines a new pump delivery system, a smartphone-like user interface and an information technology system that shares infusion data with the patient’s electronic medical record. The product is designed to improve patient safety and workflow efficiency in clinical settings. The company is led by Jesse Ambrosina and is based in Amesbury, MA. Ivenix closed a $42M equity financing to support its operations. The new funding will support the company’s efforts to enter the global infusion market.
Team
No current team members are available.